A number of research firms have changed their ratings and price targets for Radius Health (NASDAQ: RDUS): 9/28/2016 – Radius Health had its “buy” rating reaffirmed by analysts at Cowen and Company. 9/28/2016 – Radius Health was given a new $85.00 price target on by analysts at Canaccord Genuity. They now have a “buy” rating […]
